Circular RNAs in body fluids as cancer biomarkers: the new frontier of liquid biopsies
Abstract Cancer is a leading cause of death worldwide, particularly because of its high mortality rate in patients who are diagnosed at late stages. Conventional biomarkers originating from blood are widely used for cancer diagnosis, but their low sensitivity and specificity limit their widespread a...
Main Authors: | Sumeng Wang, Ke Zhang, Shanyue Tan, Junyi Xin, Qianyu Yuan, Huanhuan Xu, Xian Xu, Qi Liang, David C. Christiani, Meilin Wang, Lingxiang Liu, Mulong Du |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2021-01-01
|
Series: | Molecular Cancer |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12943-020-01298-z |
Similar Items
-
Circular RNAs Are Promising Biomarkers in Liquid Biopsy for the Diagnosis of Non-small Cell Lung Cancer
by: Lanxiang Huang, et al.
Published: (2021-05-01) -
Circular RNAs and RNA Splice Variants as Biomarkers for Prognosis and Therapeutic Response in the Liquid Biopsies of Lung Cancer Patients
by: Florence de Fraipont, et al.
Published: (2019-05-01) -
Circular RNAs as potential biomarkers and therapeutics for cardiovascular disease
by: Weitie Wang, et al.
Published: (2019-05-01) -
Noncoding RNAs in Extracellular Fluids as Cancer Biomarkers: The New Frontier of Liquid Biopsies
by: Barbara Pardini, et al.
Published: (2019-08-01) -
Expression profiles of circular RNAs in colon biopsies from Crohn's disease patients by microarray analysis
by: Hu, Y.-A, et al.
Published: (2021)